121 related articles for article (PubMed ID: 26648459)
1. A novel curcumin derivative increases the cytotoxicity of raloxifene in estrogen receptor-negative breast cancer cell lines.
Taurin S; Nimick M; Larsen L; Rosengren RJ
Int J Oncol; 2016 Jan; 48(1):385-98. PubMed ID: 26648459
[TBL] [Abstract][Full Text] [Related]
2. RL71, a second-generation curcumin analog, induces apoptosis and downregulates Akt in ER-negative breast cancer cells.
Yadav B; Taurin S; Larsen L; Rosengren RJ
Int J Oncol; 2012 Sep; 41(3):1119-27. PubMed ID: 22710975
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms for the activity of heterocyclic cyclohexanone curcumin derivatives in estrogen receptor negative human breast cancer cell lines.
Somers-Edgar TJ; Taurin S; Larsen L; Chandramouli A; Nelson MA; Rosengren RJ
Invest New Drugs; 2011 Feb; 29(1):87-97. PubMed ID: 19816657
[TBL] [Abstract][Full Text] [Related]
4. RL66 a second-generation curcumin analog has potent in vivo and in vitro anticancer activity in ER‑negative breast cancer models.
Yadav B; Taurin S; Larsen L; Rosengren RJ
Int J Oncol; 2012 Nov; 41(5):1723-32. PubMed ID: 22971638
[TBL] [Abstract][Full Text] [Related]
5. Raloxifene Suppresses Tumor Growth and Metastasis in an Orthotopic Model of Castration-Resistant Prostate Cancer.
Palmer H; Nimick M; Mazumder A; Taurin S; Rana Z; Rosengren RJ
Biomedicines; 2022 Apr; 10(4):. PubMed ID: 35453603
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis induction in human breast cancer cell lines by synergic effect of raloxifene and resveratrol through increasing proapoptotic genes.
Mirzapur P; Khazaei MR; Moradi MT; Khazaei M
Life Sci; 2018 Jul; 205():45-53. PubMed ID: 29705353
[TBL] [Abstract][Full Text] [Related]
7. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of anti-proliferation of curcumin on human breast cancer cells and its mechanism].
Di GH; Li HC; Shen ZZ; Shao ZM
Zhonghua Yi Xue Za Zhi; 2003 Oct; 83(20):1764-8. PubMed ID: 14642080
[TBL] [Abstract][Full Text] [Related]
9. Coenzyme Q0 induces apoptosis and modulates the cell cycle in estrogen receptor negative breast cancer cells.
Somers-Edgar TJ; Rosengren RJ
Anticancer Drugs; 2009 Jan; 20(1):33-40. PubMed ID: 18830129
[TBL] [Abstract][Full Text] [Related]
10. In vitro mechanism of action for the cytotoxicity elicited by the combination of epigallocatechin gallate and raloxifene in MDA-MB-231 cells.
Stuart EC; Jarvis RM; Rosengren RJ
Oncol Rep; 2010 Sep; 24(3):779-85. PubMed ID: 20664987
[TBL] [Abstract][Full Text] [Related]
11. The aryl hydrocarbon receptor mediates raloxifene-induced apoptosis in estrogen receptor-negative hepatoma and breast cancer cells.
O'Donnell EF; Koch DC; Bisson WH; Jang HS; Kolluri SK
Cell Death Dis; 2014 Jan; 5(1):e1038. PubMed ID: 24481452
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and cytotoxic potential of heterocyclic cyclohexanone analogues of curcumin.
Yadav B; Taurin S; Rosengren RJ; Schumacher M; Diederich M; Somers-Edgar TJ; Larsen L
Bioorg Med Chem; 2010 Sep; 18(18):6701-7. PubMed ID: 20728364
[TBL] [Abstract][Full Text] [Related]
13. Oridonin induces apoptosis, inhibits migration and invasion on highly-metastatic human breast cancer cells.
Wang S; Zhong Z; Wan J; Tan W; Wu G; Chen M; Wang Y
Am J Chin Med; 2013; 41(1):177-96. PubMed ID: 23336515
[TBL] [Abstract][Full Text] [Related]
14. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines.
Thompson EW; Paik S; Brünner N; Sommers CL; Zugmaier G; Clarke R; Shima TB; Torri J; Donahue S; Lippman ME
J Cell Physiol; 1992 Mar; 150(3):534-44. PubMed ID: 1537883
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
Liu H; Zang C; Emde A; Planas-Silva MD; Rosche M; Kühnl A; Schulz CO; Elstner E; Possinger K; Eucker J
Eur J Pharmacol; 2008 Sep; 591(1-3):43-51. PubMed ID: 18588872
[TBL] [Abstract][Full Text] [Related]
16. Curcumin inhibition of integrin (alpha6beta4)-dependent breast cancer cell motility and invasion.
Kim HI; Huang H; Cheepala S; Huang S; Chung J
Cancer Prev Res (Phila); 2008 Oct; 1(5):385-91. PubMed ID: 19138983
[TBL] [Abstract][Full Text] [Related]
17. Curcumin and paclitaxel induce cell death in breast cancer cell lines.
Calaf GM; Ponce-Cusi R; Carrión F
Oncol Rep; 2018 Oct; 40(4):2381-2388. PubMed ID: 30066930
[TBL] [Abstract][Full Text] [Related]
18. Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo.
Chattopadhyay M; Kodela R; Nath N; Barsegian A; Boring D; Kashfi K
Biochem Pharmacol; 2012 Mar; 83(6):723-32. PubMed ID: 22209867
[TBL] [Abstract][Full Text] [Related]
19. Induction of antiproliferation and apoptosis in estrogen receptor negative MDA-231 human breast cancer cells by mifepristone and 4-hydroxytamoxifen combination therapy: a role for TGFbeta1.
Liang Y; Hou M; Kallab AM; Barrett JT; El Etreby F; Schoenlein PV
Int J Oncol; 2003 Aug; 23(2):369-80. PubMed ID: 12851686
[TBL] [Abstract][Full Text] [Related]
20. Sequence-dependent administration of 5-fluorouracil maintains methotrexate antineoplastic activity in human estrogen-negative breast cancer and protects against methotrexate cytotoxicity in human bone marrow.
Das JR; Fryar-Tita EB; Zhou Y; Green S; Southerland WM; Bowen D
Anticancer Res; 2007; 27(6B):3791-9. PubMed ID: 18225534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
